Revere Asset Management Inc Purchases New Shares in Direxion Daily S&P Biotech Bull 3X ETF $LABU

Revere Asset Management Inc acquired a new stake in Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABUFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,279 shares of the company’s stock, valued at approximately $666,000. Direxion Daily S&P Biotech Bull 3X ETF makes up approximately 0.3% of Revere Asset Management Inc’s holdings, making the stock its 20th largest position. Revere Asset Management Inc owned about 0.11% of Direxion Daily S&P Biotech Bull 3X ETF at the end of the most recent quarter.

A number of other large investors have also modified their holdings of LABU. Foundations Investment Advisors LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF in the 4th quarter valued at about $797,000. SLT Holdings LLC purchased a new position in Direxion Daily S&P Biotech Bull 3X ETF during the fourth quarter worth approximately $797,000. Millennium Capital Advisors LLC purchased a new position in Direxion Daily S&P Biotech Bull 3X ETF during the fourth quarter worth approximately $648,000. Valued Retirements Inc. acquired a new stake in Direxion Daily S&P Biotech Bull 3X ETF in the second quarter valued at approximately $454,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3X ETF in the first quarter valued at approximately $166,000.

Direxion Daily S&P Biotech Bull 3X ETF Stock Up 2.7%

Shares of Direxion Daily S&P Biotech Bull 3X ETF stock traded up $7.09 on Monday, reaching $268.39. The company’s stock had a trading volume of 212,468 shares, compared to its average volume of 560,532. The stock has a 50-day moving average price of $282.15 and a 200-day moving average price of $219.50. Direxion Daily S&P Biotech Bull 3X ETF has a 52-week low of $74.95 and a 52-week high of $341.93.

About Direxion Daily S&P Biotech Bull 3X ETF

(Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Further Reading

Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABUFree Report).

Institutional Ownership by Quarter for Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU)

Receive News & Ratings for Direxion Daily S&P Biotech Bull 3X ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3X ETF and related companies with MarketBeat.com's FREE daily email newsletter.